The Role of Pulsed Dye Laser Therapy in the Management of Burn Scars
NCT ID: NCT01488240
Last Updated: 2024-12-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
6 participants
INTERVENTIONAL
2012-11-01
2027-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objectives:
To determine the benefit of pulsed dye laser treatment in improving burn scar height, texture, vascularity and pliability in acute burn injury.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Proximal
part of scar proximal to heart
pulsed dye laser
laser energy
Distal
part of scar distal to heart
pulsed dye laser
laser energy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pulsed dye laser
laser energy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* living in Winnipeg
* scar age one to 6 months
* Fitzpatrick I-III skin type
Exclusion Criteria
* active infection
* previous scar treatment with steroid injection or interferon
* established disposition towards keloid scarring
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Manitoba
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
S Logsetty, MD
Role: PRINCIPAL_INVESTIGATOR
University of Manitoba
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Manitoba
Winnipeg, Manitoba, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Justin P Gawaziuk, MSc
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B2011: 074
Identifier Type: -
Identifier Source: org_study_id